|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Genito-Urinary Cancer Research Group, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester and 2Department of Urology, Christie Hospital NHS Foundation Trust, Manchester; and 3Department of Urology, Salford Royal NHS Foundation Trust, Salford, United Kingdom
Submitted 1 May 2008 ; accepted in final form 2 July 2008
| ABSTRACT |
|---|
|
|
|---|
kidney; renal cancer
Isolation of adult stem cells (ASC) has proven difficult due to the lack of clearly defined ASC markers. Goodell et al. (12) demonstrated that hemopoietic stem cells (HSC) could be isolated by the ability of SCs to efflux Hoechst 33342 and form a side population (SP) on FACS analysis (12). This method of SC isolation has been adapted for solid tissues such as the prostate (4) and, recently, unfractionated normal human renal tissue (15).
In this study we have utilized the Hoechst 33342 dye efflux technique to phenotypically characterize the SP from matched normal and malignant human renal specimens.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Isolation of Primary Renal Cells
Normal kidney specimens from patients undergoing non-renal cancer surgery and paired malignant and macroscopically normal tissue samples were taken from patients undergoing surgery for RCC, with local ethical committee approval and informed consent. Specimens were digested overnight in the presence of collagenase type 1 (200 U/ml in RPMI 1640 medium, 2% FCS) on a shaker at 37°C. Live cells were isolated over metrizamide (1.08 g/ml), and fibroblasts were depleted by differential centrifugation (360 g, 1 min).
Hoechst 33342 Staining
CD45-depleted cells were stained with Hoechst 33342 ± 50 µM verapamil (4). Cells were resuspended in Hoechst buffer (HBSS; 10% FCS, 20 mM HEPES, 1% D-glucose) and stained with 5 µM Hoechst 33342 and CD45-FITC (1:500) for 75 min on a shaking platform at 37°C. Cell cycle status was studied by Hoechst 33342 and pyronin Y (0.5 ng/ml) staining. Cells were washed and resuspended in ice-cold Hoechst buffer before immediate FACS analysis. Flow cytometry was carried out using a Becton Dickinson FACS Vantage SE Flow Cytometer. Hoechst blue was measured with a 424/44 broad-pass (BP) filter and Hoechst red with a 675/20 BP filter.
Colony-Forming Efficiency
Cells were cultured in the presence of an irradiated (50 Gray) STO feeder layer in AR-5 media [50:50 DMEM and Ham's F12 media supplemented with insulin (200 µg/l), transferrin (100 µg/l), selenium (25 nM), hydrocortisone (18.2 µg/l), epidermal growth factor (1 µg/l), 10 mM ethanolamine, 10 mM HEPES, FCS (5%), bovine serum albumin (0.2%), O-phosphorylethanolamine (1.4 mg/l), triiodothyronine (0.68 µg/1), and 0.5 mM sodium pyruvate] at 37°C and 5% CO2. Media was changed twice weekly, and colonies (>32 cells) were counted. Colonies were fixed in 50:50 methanol and acetone and stained with anti-pan cytokeratin.
Long-Term Culture
SP and NSP from RCC and NK were plated in T-25 flasks in AR-5 media at 37°C and 5% CO2. Confluent cells were passaged until senescence. Established cultures from both SP and NSP were restained with Hoechst 33342 and pyronin Y.
Spheroid Culture in 3D Matrigel
Spheroids were cultured as defined for prostate spheroids (18). Briefly, SP and NSP were resuspended in ice-cold AR-5 media and mixed 1:1 with growth factor-reduced Matrigel and rat tail type 1 collagen. Two hundred-fifty-microliter aliquots were plated onto 0.4-µm culture inserts (Becton Dickinson) and set at 37°C for 30 min before transfer to an irradiated STO feeder layer. Media was refreshed every 3 days. Spheroids were viewed using an inverted Olympus BX51 microscope, and images were captured (Soft Imaging Systems). Formalin-fixed, paraffin-embedded spheroids were sectioned and stained.
Immunohistochemistry
Cells adhered to poly-L-lysine-coated slides were fixed in 4% formalin and permeabilized with methanol. Slides were blocked using secondary antibody host serum before being stained with p21cip1/waf1, p27kip1, E-cadherin, N-cadherin, Ki-67 (Dako Cytomation), anti-pan cytokeratin clone 11 (Sigma-Aldridge), CD44, CD29 (Vector Laboratories, Burlingame, CA), CD133, β-catenin, cleaved notch (Miltenyi Biotec), Pax-2 (Zymed Laboratories, South San Francisco, CA), SHH, Notch-1 (Santa Cruz Technologies, Santa Cruz, CA), and Musashi-1 (courtesy of R. Clarke, Manchester, UK) overnight at 4°C. Slides were treated with H2O2 followed by addition of biotinylated secondary antibodies, Vector Elite ABC and 3–3 diaminobenzidine superoxide substrate (DAB), and counterstained with hematoxylin.
Statistics
All values are presented as means ± SE. All assays were compared by use of a two-tailed Student's t-test. A threshold of significance was set at P < 0.05.
| RESULTS |
|---|
|
|
|---|
The Hoechst 33342 staining protocol was standardized for renal epithelial-enriched populations using previously described methods (3, 4), and CD45–ve profiles were generated from both NK (n = 19) and RCC (n = 15) (Fig. 1A). A consistent observation using matched paired specimens (n = 10) was that RCC samples contained a higher percentage of CD45+ve lymphocytes compared with NK (49.6 ± 5.1 vs. 25.2 ± 5.3%, respectively; P < 0.0002).
|
SP Characterization
Immunohistochemistry. Phenotyping was performed on matched pairs of NK and RCC-SP and NSP cells (Table 1; n = 4). Epithelial cells of mesenchymal origin were confirmed by pan-cytokeratin and vimentin staining. Differential cadherin expression was observed between the SP and NSP, with SP containing more cells expressing both E- and N-cadherin, although E-cadherin did not achieve significance in RCC (P = 0.16). In a comparison of the differential expression of cadherins between NK and RCC specimens, only SP cells showed a significant difference, with fewer cells expressing E- and N-cadherins in the RCC-SP.
|
0.05) (Fig. 2B and Table 1). In a comparison of the NK and RCC-SP marker profile, there was no difference except in relation to CD133, which was expressed to a greater extent in NK-SP (15.3 ± 3.7 vs. 3.3+0.7%; P = 0.03).
|
Taken together the marker profiles show that NK and RCC-SP are distinct, with putative stem enrichment in both cancer and non-cancer. However, the two types cannot be readily differentiated by this panel of markers.
Proliferative potential. Both NK and RCC-SP and NSP (n = 4) formed well-defined, closely compacted colonies of epithelial cells, as confirmed by positive pan-cytokeratin staining (data not shown). Figure 3A shows that SP cells from both NK and RCC-SP had significantly higher CFE than the NSP (50.8 ± 3.3 vs. 12.6 ± 2.9%; P < 0.0001 and 16.5 ± 4.4 vs. 6.8 ± 2.8%; P < 0.002 for NK and RCC, respectively) and that the NK-SP had a significantly greater CFE compared with RCC-SP (P < 0.0001). However, the SP had a greater proliferative potential when clonal expansion was measured. This was especially marked in the RCC populations, as demonstrated in LTC. Although SP and NSP from both NK (n = 4) and RCC (n = 3) achieved confluency at the same rate (7.7 ± 0.31 days; P = 0.539), both normal and malignant SPs (9.5 ± 0.98 and 9 ± 1 for NK and RCC, respectively; P = 0.764) underwent a significantly (P = 0.01057) greater number of passages than their corresponding NSPs (6.5 ± 0.65 and 4.5 ± 2.5 for NK and RCC, respectively; P = 0.332) (Fig. 3, B and C). This resulted in the NK-SP having greater cell fold-expansion (99.25x) and a massive expansion for RCC-SP cells (823.5x), SP compared with their respective NSP. It is important to note that the overall cellular expansion in RCC was considerably higher than that measured in NK (4.42x and 5.05x for SP and NSP, respectively).
|
Live cells were CD45–ve, showing that the original FACs sorts were not contaminated with lymphocytes (Fig. 4A). Both NK-SP and NSP cultures gave rise to a verapamil-sensitive SP (R3) on staining with Hoechst 33342 (30.03 ± 2.7 and 26.7 ± 8.3%, respectively). This percentage was significantly greater than the SP percentage isolated from primary NK tissue (4.4 ± 0.6%; P < 0.007) (Fig. 4B). Cell cycle analysis revealed differences in the SPs' and NSPs' SP with quiescence (R4) maintained at a similar level to that seen in the original SP G0 population (13.8 ± 2.02 vs. 14.1 ± 3.5%; P = 0.95) only in cells cultured from the SP fraction.
|
4 mm) spheroids (Fig. 5A) revealed a central lumen (Fig. 5B) surrounded by multiple layers of cells.
|
| DISCUSSION |
|---|
|
|
|---|
In this study, the overall cellular population was enriched for epithelial cells before SP analysis. This resulted in the isolation of a larger SP (3.8 ± 0.4 and 5.9 ± 0.9% for NK and RCC, respectively) than previously identified (15). This is in keeping with rodent studies in which embryonic and adult renal SP account for between 0.03 and 5.1% of the cells (14, 16). This variability could be explained by the differences in the isolation techniques and the well-known variability of SP due to different FACS conditions (20). The increased SP in malignant tissue is higher than that of other solid tumors such as prostate cancer, which shows a 2- to 10-fold reduction of SP cells in malignant tissue (4).
The SP phenotype is enriched for cells with SC-like properties, such as quiescence (G0), elaboration of stem markers, augmented growth, and the ability to form differentiated structures. These data combined with data regarding the percentage of SP cells in G1 are in keeping with SP isolated from prostatic tissue (3). The low expression of the proliferative marker Ki-67 in both NK-SP and NSP is consistent with the finding that in randomly selected kidney sections
1:1,000 cells exhibit mitotic figures (23). The higher expression of Ki-67 in RCC-NSP compared with SP (although the difference did not achieve significance) runs counter to the suggestion that Ki-67 may be used as a marker of SP cells in malignancy (7). Back gating the SP G0 fraction onto FSC and SSC showed that these cells are small, with little cytoplasm, a finding commensurate with the fact that SCs are smaller than differentiated cells. Cell cycle status was further studied using p21cip1/waf1 and p27kip1 (9, 10). These cell cycle markers were expressed more highly in SP than NSP cells. p27kip1 expression was higher than for p21cip1/waf1 in both the NK and RCC subpopulations. This finding would corroborate with cell cycle analysis whereby a much greater proportion of the SP cells was noted in G0. However, 80% of the SP were in G1, suggesting that the renal SP, like other tissue SPs, is still heterogeneous and will need to be enriched further to isolate this SC-like population (7).
Evidence for SP enrichment for cells with stemlike functional properties is supported by the in vitro growth characteristics. CFE and LTC assays showed that both NK and RCC-SP contained cells with a higher proliferative potential than their respective NSP and were able to give rise to differentiated spheroids, unlike NSP cells. A particularly interesting feature was that RCC-SP had a much greater rate of clonal expansion than NK-SP in the absence of an accelerated cycling rate. The reasons for this remain to be elucidated but may include the inhibition of apoptosis, something which was not measured in this study. LTC also showed that the SP G0 population was maintained and expanded upon passage. This suggests that the SP was able to undergo asymmetric cell division, a key characteristic of SCs, which has been observed in neuroblastoma cell line SP subpopulations (13). The increase in SP with culture has also been noted with primary human keratinocyte SP, where the number of SP cells isolated increased 250-fold upon passage (19).
Phenotypic characterization revealed that the SP isolated using Hoechst 33342 is enriched for cells with stemlike characteristics but it is still heterogeneous; as such, determination of a definitive marker profile of a renal SC has not been possible. However, the SP cadherin expression profile suggests that the SP may reside within either the distal or proximal tubules. Cadherins are known to play important roles in the development and maintenance of tissue architecture and in carcinogenesis (21, 28). In the normal kidney, the proximal tubular cells mainly express N-cadherin (25), whilst E-cadherin expression is restricted to distal tubules (2). There was predominant expression of N- and E-cadherins in the NK-SP subpopulation, which decreased in RCC-SP (Fig. 2A). This decreased expression may in part explain the loss of cell-cell adhesion, leading to metastasis, a finding also seen in prostate cancer carcinogenesis (5). LTC experiments showed that both SP monolayers underwent a similar number of passages but the cell fold-expansion of RCC-SP, compared with NSP, was higher, at 823.5-fold compared with 99.25-fold for NK-SP. By combining the cadherin expression with the proliferative data, it can be hypothesized that the upregulation of RCC-SP proliferation combined with the reduced CFE, due to downregulated cell-cell adherence, may be the reason for the aggressive metastatic tendency observed clinically in renal cancer.
SCs, which have a prolonged lifespan, are more prone to accumulation of mutations (23) and the dysregulation of signaling pathways regulating SC self-renewal. This has led to the hypothesis for the existence of cancer SC (24). The canonical Wnt signaling cascade, Sonic HedgeHog (SHH) and Notch pathways, are key for maintaining SC self-renewal and, in the case of HSC, multipotentiality (24, 27). Loss of SHH has been associated with renal defects like hydroureter, suggesting a role in epithelial-mesenchymal interaction in renal embryogenesis (22), and Notch signaling has a crucial role in cell fate determination in proximal tubule cells and podocytes during S-shaped body formation (8). β-Catenin, a downstream activator of Wnt signaling, SHH, and both cleaved Notch and Notch-1 were expressed more widely in SP compared with NSP, without any differences in expression between NK and RCC. The increased expression of Notch-1 in SP correlates with the increased expression of Notch signaling pathway members in a mouse renal SP gene expression profile (7).
CD133 has been used as a marker of SCs in many tissues, including the kidney (6). It has been demonstrated that CD133+ve cells, which comprise 0.8–1.2% of the cells from the renal cortex, were able to proliferate and self-renew and could differentiate into epithelial or endothelial cells both in vitro and in vivo. They expressed the mesenchymal SC markers CD44 and CD29 and the embryonal renal marker PAX-2. The NK-SP isolated in this study was enriched for cells expressing CD133, CD29, CD44, and PAX-2. The higher proportion of CD133+ve cells in our study, 15.3 ± 3.7%, compared with 0.8–1.2% noted by Bussolati et al. (6), can be explained by our method of enrichment using FSC and SSC live cell gating and CD45 depletion. As evident from the very low numbers of CD133+ve cells in NK-NSP and both the RCC subpopulations, the loss of CD133 might be a very early event in SC differentiation and possibly in malignant transformation. This finding runs counter to the notion that CD133 is a definitive SC marker in solid tumors.
In summary, the SP is enriched for cells with a high proliferative capacity, expressing putative SC markers and the ability to produce differentiated spheroids. The SP is maintained on passage, but SP cell cycle status combined with phenotypic characteristics suggest that the SP is a heterogeneous population. This confirms the notion that the terms "side population cell" and "stem cell" cannot be used interchangeably (7). However, further enrichment of this population will enable detailed future study of unexpanded cancer stem cells.
Conclusion
Both normal and malignant renal epithelial cells contain SP which are enriched for cells with SC-like properties. The population is however, heterogeneous, confirming that the terms side population cell and stem cell cannot be used interchangeably.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |